μ阿片受体的内吞抑制吗啡耐受的形成

中国临床药理学与治疗学 ›› 2012, Vol. 17 ›› Issue (10): 1185-1190.

μ阿片受体的内吞抑制吗啡耐受的形成

吕庆琴, 陈霆隽, 洪炎国

福建师范大学生命科学学院,福建省发育和神经生物学重点实验室,福州 350108,福建

收稿日期:2012-07-07 修回日期:2012-09-14 发布日期:2012-10-19
通讯作者: 洪炎国,通信作者,男,教授,博士生导师,主要研究方向为疼痛机制的研究。Tel: 0591-22868211 E-mail: yhong@fjnu.edu.cn
作者简介:吕庆琴,女,硕士研究生,主要研究方向为疼痛机制的研究。Tel: 18950494524 E-mail: 0306lqq@163.com
基金资助:
国家自然科学基金资助项目(30970985, 31171072)

Endocytosis of μ opioid receptors inhibits morphine tolerance

LV Qing-qin, CHEN Ting-jun, HONG Yan-guo

Key Laboratory of Developmental Biology and Neuroscience in Fujian Province, College of Life Science, Fujian Normal University, Fuzhou,350108, Fujian, China

Received:2012-07-07 Revised:2012-09-14 Published:2012-10-19

摘要/Abstract

摘要： 阿片类药物是至今最有效的镇痛药,但是长期应用会产生药物耐受,大大限制了其临床应用。μ阿片受体和特定的激动剂结合后会出现内吞。研究发现,μ阿片受体是否内吞与耐受的发生有密切关系;加强μ阿片受体的内吞能够抑制受体耐受。不同的激动剂导致μ阿片受体内吞的能力是不同的;其导致耐受的能力和导致内吞的能力呈负相关。激动剂越容易引起μ受体内吞,就越不容易产生吗啡耐受。内吞的作用在于能抑制过度刺激μ受体而导致的环腺苷酸(cyclic adenosine monophosphate,cAMP)等兴奋性信号通路的激活,而内吞的μ受体也会很快回到细胞膜上,恢复和阿片类药物结合后激活抑制性GTP结合蛋白的能力。因此,对受体的内吞和其后迁移过程展开研究,可能为慢性疼痛的治疗找到新的路径。

关键词: μ阿片受体;, 吗啡耐受, 受体内吞, GTP结合蛋白信号通路

Abstract: Opioids are the most effective analgesics. However, prolonged administration of morphine, the representative of opioids, results in tolerance, limiting the therapeutic utility of opiate drugs. Studies have recently suggested that endocytosis of μ opioid receptors attenuates opioid tolerance. The ability of inducing endocytosis of opioid receptor is agonist-dependent. It has been shown that the endocytotic efficacy of opioids are negatively correlated with opioid tolerance. Receptor internalization reduced adaptive changes in signaling pathways that are involved in the development of opioid tolerance. Moreover, endocytosised μ-opioid receptors are rapidly recycled back to the cell membrane surface resuming their normal function. Therefore, tolerance does not occur. Thus, the study of receptor endocytosis and trafficking following the activation of the receptors can help the therapy for chronic pain.

Key words: μ opioid receptors;, Morphine tolerance, Receptor internalization, G protein signaling pathways

中图分类号:

R388
Q42

吕庆琴, 陈霆隽, 洪炎国. μ阿片受体的内吞抑制吗啡耐受的形成[J]. 中国临床药理学与治疗学, 2012, 17(10): 1185-1190.

LV Qing-qin, CHEN Ting-jun, HONG Yan-guo. Endocytosis of μ opioid receptors inhibits morphine tolerance[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(10): 1185-1190.

参考文献

[1] Simon EJ.Subunit structure and purification of opioid receptors[J]. Recept Res, 1987, 7(1/2/3/4): 105-132.
[2] Zollner C, Schafer M.Opioids in anesthesia[J]. Anaesthesist, 2008, 57(7): 729-740.
[3] Tai YH,Wang YH, Wang JJ, et al.Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats[J]. Pain, 2006, 124(1/2): 77-86.
[4] Matthes HW, Maldonado R, Simonin F, et al.Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene[J]. Nature, 1996, 383(6603): 819-823.
[5] Harrison LM, Kastin AJ, Zadina JE.Opiate tolerance and dependence: receptors, G-proteins, and antiopiates[J]. Peptides, 1998, 19(9): 1603-1630.
[6] Ray SB, Gupta H, Gupta YK.Up-regulation of mu-opioid receptors in the spinal cord of morphine tolerant rats[J]. Biosci, 2004, 29(1): 51-56.
[7] He L, Fong J, von ZM, et al. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization[J]. Cell, 2002, 108(2): 271-282.
[8] Kim JA, Bartlett S, He L, et al.Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence[J]. Curr Biol, 2008, 18(2): 129-135.
[9] Koch T, Widera A, Bartzsch K, et al.Receptor endocytosis counteracts the development of opioid tolerance[J]. Mol Pharmacol, 2005, 67(1): 280-287.
[10] Whistler JL, Chuang HH, Chu P, et al.Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction[J]. Neuron, 1999, 23(4): 737-746.
[11] Hull LC, Llorente J, Gabra BH, et al.The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy[J]. Pharmacol Exp Ther, 2010, 332(3): 1127-1135.
[12] Sternini C, Brecha NC, Minnis J, et al.Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors[J]. Neuroscience, 2000, 98(2): 233-241.
[13] Von ZM, Svingos A, Haberstock-Debic H, et al.Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs[J]. Curr Opin Neurobiol, 2003, 13(3): 348-353.
[14] Koch T, Schulz S, Schroder H, et al.Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization[J]. Biol Chem, 1998, 273(22): 13652-13657.
[15] Zeitz KP, Malmberg AB, Gilbert H, et al.Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice[J]. Pain, 2001, 94(3): 245-253.
[16] Wang HL.A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization[J]. Neuropharmacology, 2000, 39(3): 353-363.
[17] Narita M, Matsumura Y, Ozaki S, et al.Role of the calcium/calmodulin-dependent protein kinase ii (CaMKII) in the morphine-induced pharmacological effects in the mouse[J]. Neuroscience, 2004, 126(2): 415-421.
[18] Doll C, Konietzko J, Poll F, et al.Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies[J]. Br Pharmacol, 2011, 164(2): 298-307.
[19] Smith FL, Javed RR, Smith PA, et al.PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice[J]. Pharmacol Res, 2006, 54(6): 474-480.
[20] He SQ, Zhang ZN, Guan JS, et al.Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation[J]. Neuron, 2011, 69(1): 120-131.
[21] Koch T, Brandenburg LO, Liang Y, et al.Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization[J]. Neurochem, 2004, 88(3): 680-688.
[22] Grecksch G, Bartzsch K, Widera A, et al.Development of tolerance and sensitization to different opioid agonists in rats[J]. Psychopharmacology(Berl), 2006, 186(2): 177-184.
[23] Borgland SL, Connor M, Osborne PB, et al.Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors[J]. Biol Chem, 2003, 278(21): 18776-18784.
[24] Wang YH, Sun JF, Tao YM, et al.Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence[J]. Acta Pharmacol Sin, 2010, 31(4): 393-398.
[25] Martini L,Whistler JL.The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence[J]. Curr Opin Neurobiol, 2007, 17(5): 556-564.
[26] Koch T, Hollt V.Role of receptor internalization in opioid tolerance and dependence[J]. Pharmacol Ther, 2008, 117(2): 199-206.
[27] Sharma SK, Klee WA, Nirenberg M.Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance[J]. Proc Natl Acad Sci USA, 1975, 72(8): 3092-3096.
[28] Shen KF, Crain SM.Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions[J]. Brain Res, 1990, 531(1/2): 1-7.
[29] Avidor-Reiss T, Nevo I, Levy R, et al.Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma[J]. Biol Chem, 1996, 271(35): 21309-21315.
[30] Finn AK, Whistler JL.Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal[J]. Neuron, 2001, 32(5): 829-839.
[31] Lopez-Gimenez JF,Vilaro MT, Milligan G.Morphine desensitization, internalization, and down- regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation[J]. Mol Pharmacol, 2008, 74(5): 1278-1291.
[32] Fuxe K, Borroto-Escuela DO, Marcellino D, et al.GPCR heteromers and their allosteric receptor-receptor interactions[J]. Curr Med Chem, 2012, 19(3): 356-363.
[33] Agnati LF, Guidolin D, Leo G, et al.Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms[J]. Recept Signal Transduct Res, 2011, 31(5): 315-331.